1
0
0
(1 - 14 von 17
)
Emily Becker - Acemap - DDE Scholar
ddescholar.acemap.info
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study BMC GASTROENTEROLOGY · Laura Mühl · Emily ... › au...
Baseline levels of dynamic CD4+ T cell...
www.proquest.com
Clarissa Allner, Michaela Melde, Emily Becker, Friederike Fuchs, Laura Mühl, Entcho Klenske, Lisa Müller,. Nadine Morgenstern, Konstantin Fietkau, Simon ...
a cohort study - ProQuest
www.proquest.com
von L Mühl · · Zitiert von: 10 — Laura Mühl, Emily Becker, Tanja M. Müller, Raja Atreya, Imke Atreya, Markus F. Neurath and Sebastian Zundler*. Abstract. Background: Vedolizumab has become ... › openview › 1.pdf
α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is ...
www.deepdyve.com
— Melde, Michaela, Tanja M. Müller, Ines Schneider, Carol-Immanuel Geppert, Laura Mühl, Laura Besendorf, Clarissa Allner, Emily Becker, ... › doc-...
Expression and function of α4β7 integrin predict the success of ...www.sciencedirect.com › science › article › pii
www.sciencedirect.com
Laura Mühl a , Michaela Melde a , Donata Lissner b , Eleni Mantzivi b , Rainer Glauben b , Francesco Vitali a , Emily Becker a , Imke Atreya a c , Tanja M ...
Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 …late...
bmcgastroenterol.biomedcentral.com
Clarissa Allner, Michaela Melde, Emily Becker, Friederike Fuchs, Laura Mühl, Entcho Klenske, Lisa Müller, Nadine Morgenstern, Konstantin ...
Choosing therapy on the basis of disease classifications in ...link.springer.com › article
link.springer.com
Laura Mühl, Emily Becker, … Sebastian Zundler. Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid? 04 January Robert Battat ...
Clinical experiences and predictors of success of treatment with...
link.springer.com
· Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study. Laura Mühl ,; Emily Becker ,; Tanja ...
10 - OUCIouci.dntb.gov.ua › ...
ouci.dntb.gov.ua
Ines Schneider, Clarissa Allner, Laura Mühl, Michaela Melde, Donata Lissner, Eleni Mantzivi, Rainer Glauben, Francesco Vitali, Emily Becker, Imke Atreya, Tanja ...
Clinical experiences and predictors of success of treatment ...
opus4.kobv.de
von L Mühl · · Zitiert von: 10 — Laura Mühl, Emily Becker, Tanja M. Müller, Raja Atreya, Imke Atreya, Markus F. Neurath, Sebastian Zundler. Background Vedolizumab has become ... › year › docId
Clinical experiences and predictors of success of treatment with...
www.proquest.com
of success of treatment with vedolizumab in IBD patients: a cohort study. Laura Mühl, Emily Becker, Tanja M. Müller, Raja Atreya, Imke Atreya, Markus F. Neurath ...
World Journal of Clinical Cases - Baishideng Publishing Groupwww.wjgnet.com › CitedArticles › wjcc.v7.i
www.wjgnet.com
Michaela Melde, Tanja M. Müller, Ines Schneider, Carol-Immanuel Geppert, Laura Mühl, Laura Besendorf, Clarissa Allner, Emily Becker, Imke Atreya, Francesco ...
OPUS FAU | Baseline levels of dynamic CD4+ T cell adhesion to...
opus4.kobv.de
· Clarissa Allner, Michaela Melde, Emily Becker, Friederike Fuchs, Laura Mühl, Entcho Klenske, Lisa Müller, Nadine Morgenstern, Konstantin ...
Clinical experiences and predictors of success of Europe PMCeuropepmc.org › article › pmc › pmc
europepmc.org
· Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study. Laura Mühl, Emily Becker, Tanja M.
Alle Infos zum Namen "Laura Mühl"
Verwandte Suchanfragen zu Laura Mühl
| Junior Project Michaela Melde Sebastian Henneböhl | Laura Elise Mühl Niklas Jansen |
Person "Mühl" (4) Vorname "Laura" (39952) Name "Mühl" (621) |
sortiert nach Relevanz / Datum